Hard imes For Cancer Control – Six Contracts Ended; Rochester’s Community Proposal Rejected
In Brief: In Vitro Systems Will Be 90% Reliable, Ames Says; GAO Asks For Reassessment of Saccharin
DeVita’s “Radical” Statement – Resectability Rate Should Be The Cure Rate
Rauscher Disappointed In CREG Progress
Cancer Commission Surveying for Pill, Hepatoma Association
President Accepts Rauscher Resignation
NCI Urged To Back Ultrasounds Studies
Schmidt Attempted To Answer Critics
Trending Stories
- FDA’s second rejection of Replimune’s melanoma treatment stirs worry among oncologists, patients
“Patients are owed another review.” - Mayo Clinic AI detects pancreatic cancer up to three years before diagnosis, validation study finds
- Mt. Sinai forms committee to probe Epstein links to breast center founder Eva Dubin, other faculty members
- ASCO & The Conquer Cancer Foundation announce merit awards
- CBER Director Vinay Prasad dared to “say no to drugs”
- By adding specialists to USPSTF, Kennedy would reshape the functioning and decisions of the influential health panel
Ransohoff: “The task force’s job is to describe the evidence fairly, and that’s done best with objective, detached methodologists”









